Skip to content

Progression Assessment of PXE-associated Alterations

Natural History and Structural Consequences of a Diseased Bruch's Membrane in Pseudoxanthoma Elasticum (PXE)

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07048106
Acronym
PAPA
Enrollment
100
Registered
2025-07-02
Start date
2024-09-01
Completion date
2027-10-31
Last updated
2025-07-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Angioid Streaks, Grönblad-Stranberg Disease (Pseudoxanthoma Elasticum), Peau d'Orange, Pseudoxanthoma Elasticum

Keywords

ABCC6, Pseudoxanthoma elasticum, PXE, Angioid streaks, Peau d'orange, Grönblad-Strandberg Syndrome

Brief summary

This monocentric clinical observational study at the University Eye Hospital Bonn investigates the natural history and structural consequences of a diseased Bruch's membrane (BrM) in Pseudoxanthoma elasticum (PXE). The study includes four main objectives: 1. Direct Bruch's Membrane Alterations: Longitudinal analysis of BrM reflectivity using high-resolution OCT to assess correlations with disease progression 2. Choriocapillaris Flow Deficits: Evaluation of choriocapillaris (CC) perfusion in relation to BrM calcification, aiming to clarify whether CC deficits precede or result from BrM changes 3. Retinal Atrophy Progression: Monitoring the development and expansion of retinal atrophic areas over two years, including correlations with specific features like reticular pseudodrusen and hyperreflective spots 4. Genotype-Phenotype Correlation: Analysis of different ABCC6 gene mutations to identify correlations with imaging features and disease severity, potentially guiding future personalized therapeutic strategies The study will recruit 100 PXE patients and 100 controls, with data collection over 10 years. It involves non-invasive imaging and blood sampling. No direct benefit is expected for participants, but the findings may inform future clinical trials and improve patient counseling.

Interventions

None listed

Sponsors

University Hospital, Bonn
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
Yes

Inclusion criteria

for PXE cohort: * PXE based on the criteria of Plomp et al. * Clear ocular media * Ability to perform the tasks of the study protocol (i.e., holding the head still for image aquisition)

Exclusion criteria

* Any confounding ocular disease not associated with PXE * Systemic diseases hindering the study examinations

Design outcomes

Primary

MeasureTime frameDescription
Eccentricity of 'Peau d'orange' over 2 years2 years'Peau d'orange' will be measured in en-face imaging \[mm2\]

Secondary

MeasureTime frameDescription
Bruch's Membrane changes on High-Resolution Optical coherence tomography (OCT)2 yearsBruch's membrane will be qualitatively graded on High resolution OCT (integrity, breaks, ...)
Choriocapillaris flow voids on Optical Coherence Tomography Angiography (OCT-A)2 yearsChoriocapillaris degeneration will be evaluated on OCT-Angiography, i.e. percent (%) of flow voids, progression over 2 years
Angioid Streak Length on Fundus Photography and Infrared Reflectance Imaging2 yearsAngioid Streaks will be measured manually with the unit \[mm\]

Countries

Germany

Contacts

Primary ContactKristina Pfau, MD, FEBO
Kristina.Pfau@ukbonn.de+49 (0)228-287 15505

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026